Skip to main content
Top
Published in: BMC Infectious Diseases 1/2008

Open Access 01-12-2008 | Research article

Risk factors for negative blood cultures in adult medical inpatients – a retrospective analysis

Authors: Boris P Ehrenstein, Vera Ehrenstein, Christine Henke, Hans-Jörg Linde, Bernd Salzberger, Jürgen Schölmerich, Thomas Glück

Published in: BMC Infectious Diseases | Issue 1/2008

Login to get access

Abstract

Background

The identification of clinical factors associated with negative blood cultures could help to avoid unnecessary blood cultures. C-reactive protein (CRP) is a well-established inflammation marker commonly used in the management of medical inpatients.

Methods

We studied the association of clinical factors, CRP levels and changes of CRP documented prior to blood culture draws with the absence of bacteremia for hospitalized medical patients.

Results

In the retrospective analysis of 710 blood cultures obtained from 310 medical inpatients of non-intensive-care wards during one year (admission blood cultures obtained in the emergency room were excluded), the following retrospectively available factors were the only independent predictors of blood cultures negative for obligate pathogens: a good clinical condition represented by the lowest of three general nursing categories (OR 4.2, 95% CI 1.8 – 9.5), a CRP rise > 50 mg/L documented before the blood culture draw (OR 2.0 95% CI 1.8–9.5) and any antibiotic treatment in the previous seven days (OR 2.0, 95% CI 1.1–3.5).

Conclusion

Including the general clinical condition, antibiotic pre-treatment and a substantial rise of CRP into the decision, whether or not to obtain blood cultures from medical inpatients with a suspected infection, could improve the diagnostic yield.
Appendix
Available only for authorised users
Literature
1.
go back to reference Povoa P: C-reactive protein: a valuable marker of sepsis. Intensive Care Med. 2002, 28: 235-243. 10.1007/s00134-002-1209-6.CrossRefPubMed Povoa P: C-reactive protein: a valuable marker of sepsis. Intensive Care Med. 2002, 28: 235-243. 10.1007/s00134-002-1209-6.CrossRefPubMed
2.
go back to reference Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999, 340: 448-454. 10.1056/NEJM199902113400607.CrossRefPubMed Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999, 340: 448-454. 10.1056/NEJM199902113400607.CrossRefPubMed
3.
go back to reference Bates DW, Cook EF, Goldman L, Lee TH: Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med. 1990, 113: 495-500.CrossRefPubMed Bates DW, Cook EF, Goldman L, Lee TH: Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med. 1990, 113: 495-500.CrossRefPubMed
4.
go back to reference Bates DW, Sands K, Miller E, Lanken PN, Hibberd PL, Graman PS, Schwartz JS, Kahn K, Snydman DR, Parsonnet J, et al: Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis. 1997, 176: 1538-1551.CrossRefPubMed Bates DW, Sands K, Miller E, Lanken PN, Hibberd PL, Graman PS, Schwartz JS, Kahn K, Snydman DR, Parsonnet J, et al: Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis. 1997, 176: 1538-1551.CrossRefPubMed
5.
go back to reference Leibovici L, Greenshtain S, Cohen O, Mor F, Wysenbeek AJ: Bacteremia in febrile patients. A clinical model for diagnosis. Arch Intern Med. 1991, 151: 1801-1806. 10.1001/archinte.151.9.1801.CrossRefPubMed Leibovici L, Greenshtain S, Cohen O, Mor F, Wysenbeek AJ: Bacteremia in febrile patients. A clinical model for diagnosis. Arch Intern Med. 1991, 151: 1801-1806. 10.1001/archinte.151.9.1801.CrossRefPubMed
7.
go back to reference de Bont ES, Vellenga E, Swaanenburg JC, Fidler V, Visser-van Brummen PJ, Kamps WA: Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br J Haematol. 1999, 107: 375-380. 10.1046/j.1365-2141.1999.01707.x.CrossRefPubMed de Bont ES, Vellenga E, Swaanenburg JC, Fidler V, Visser-van Brummen PJ, Kamps WA: Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br J Haematol. 1999, 107: 375-380. 10.1046/j.1365-2141.1999.01707.x.CrossRefPubMed
8.
go back to reference Engel A, Mack E, Kern P, Kern WV: An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection. 1998, 26: 213-221. 10.1007/BF02962366.CrossRefPubMed Engel A, Mack E, Kern P, Kern WV: An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection. 1998, 26: 213-221. 10.1007/BF02962366.CrossRefPubMed
9.
go back to reference Persson L, Engervall P, Magnuson A, Vikerfors T, Soderquist B, Hansson LO, Tidefelt U: Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis. 2004, 36: 365-371. 10.1080/00365540410020217.CrossRefPubMed Persson L, Engervall P, Magnuson A, Vikerfors T, Soderquist B, Hansson LO, Tidefelt U: Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis. 2004, 36: 365-371. 10.1080/00365540410020217.CrossRefPubMed
10.
go back to reference Byl B, Deviere J, Saint-Hubert F, Zech F, Gulbis B, Thys JP: Evaluation of tumor necrosis factor-alpha, interleukin-6 and C-reactive protein plasma levels as predictors of bacteremia in patients presenting signs of sepsis without shock. Clin Microbiol Infect. 1997, 3: 306-316. 10.1111/j.1469-0691.1997.tb00618.x.CrossRefPubMed Byl B, Deviere J, Saint-Hubert F, Zech F, Gulbis B, Thys JP: Evaluation of tumor necrosis factor-alpha, interleukin-6 and C-reactive protein plasma levels as predictors of bacteremia in patients presenting signs of sepsis without shock. Clin Microbiol Infect. 1997, 3: 306-316. 10.1111/j.1469-0691.1997.tb00618.x.CrossRefPubMed
11.
go back to reference Tokuda Y, Miyasato H, Stein GH: A simple prediction algorithm for bacteraemia in patients with acute febrile illness. QJM. 2005, 98: 813-820. 10.1093/qjmed/hci120.CrossRefPubMed Tokuda Y, Miyasato H, Stein GH: A simple prediction algorithm for bacteraemia in patients with acute febrile illness. QJM. 2005, 98: 813-820. 10.1093/qjmed/hci120.CrossRefPubMed
12.
go back to reference Rintala EM, Aittoniemi J, Laine S, Nevalainen TJ, Nikoskelainen J: Early identification of bacteremia by biochemical markers of systemic inflammation. Scand J Clin Lab Invest. 2001, 61: 523-530. 10.1080/003655101753218283.CrossRefPubMed Rintala EM, Aittoniemi J, Laine S, Nevalainen TJ, Nikoskelainen J: Early identification of bacteremia by biochemical markers of systemic inflammation. Scand J Clin Lab Invest. 2001, 61: 523-530. 10.1080/003655101753218283.CrossRefPubMed
13.
go back to reference Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA: Procalcitonin Test in the Diagnosis of Bacteremia: A Meta-analysis. Ann Emerg Med. 2007, 50: 34-41. 10.1016/j.annemergmed.2006.10.020.CrossRefPubMed Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA: Procalcitonin Test in the Diagnosis of Bacteremia: A Meta-analysis. Ann Emerg Med. 2007, 50: 34-41. 10.1016/j.annemergmed.2006.10.020.CrossRefPubMed
Metadata
Title
Risk factors for negative blood cultures in adult medical inpatients – a retrospective analysis
Authors
Boris P Ehrenstein
Vera Ehrenstein
Christine Henke
Hans-Jörg Linde
Bernd Salzberger
Jürgen Schölmerich
Thomas Glück
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2008
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-8-148

Other articles of this Issue 1/2008

BMC Infectious Diseases 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.